Brazil drives awareness of Notivisa adverse events reporting programme:
This article was originally published in Clinica
Brazil's healthcare products regulatory agency, Anvisa, is continuing its efforts to raise awareness of its new Notivisa healthcare vigilance and surveillance programme (see Clinica No 1198, p 13). The Brasilia-based agency hosted yesterday, in Sao Paulo city, the conference "Notivisa, a new paradigm in healthcare vigilance". Focusing specifically on the electronic reporting of adverse events and technical faults involving medical products, the meeting was addressed primarily at the medical staff and healthcare industry bodies and associations in three of the country's five regions, namely the south, southeast and centrewest.
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.